statistiche ricercatore

CECONI, Claudio

Distribuzione geografica

Continente	#
NA - Nord America	15332
EU - Europa	4141
AS - Asia	1998
SA - Sud America	15
OC - Oceania	7
Continente sconosciuto - Info sul continente non disponibili	5
AF - Africa	1
Totale	21499

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	15325
IT - Italia	1439
CN - Cina	1368
UA - Ucraina	1222
TR - Turchia	562
DE - Germania	520
GB - Regno Unito	364
FI - Finlandia	248
SE - Svezia	173
FR - Francia	65
PL - Polonia	31
BE - Belgio	16
VN - Vietnam	15
ES - Italia	12
IN - India	11
RU - Federazione Russa	11
KR - Corea	8
AU - Australia	7
CH - Svizzera	6
IR - Iran	6
AL - Albania	5
BR - Brasile	5
EU - Europa	5
ID - Indonesia	5
MX - Messico	5
NL - Olanda	5
CL - Cile	4
CO - Colombia	4
HK - Hong Kong	4
IE - Irlanda	4
JP - Giappone	4
RO - Romania	4
GE - Georgia	3
AM - Armenia	2
AT - Austria	2
CA - Canada	2
GR - Grecia	2
LT - Lituania	2
MY - Malesia	2
PT - Portogallo	2
AE - Emirati Arabi Uniti	1
AF - Afghanistan, Repubblica islamica di	1
BG - Bulgaria	1
CY - Cipro	1
DK - Danimarca	1
EC - Ecuador	1
HR - Croazia	1
HU - Ungheria	1
IL - Israele	1
MD - Moldavia	1
MM - Myanmar	1
PE - Perù	1
RS - Serbia	1
SA - Arabia Saudita	1
SG - Singapore	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
TH - Thailandia	1
ZA - Sudafrica	1
Totale	21499

Salva come PNG Salva come JPEG

Città	#
Woodbridge	2374
Fairfield	2367
Houston	1349
Jacksonville	1347
Seattle	984
Ashburn	959
Chandler	887
Ann Arbor	886
Wilmington	799
Cambridge	795
Izmir	432
Nanjing	410
Princeton	349
San Diego	232
Boardman	186
Beijing	146
Shenyang	135
Nanchang	119
Milan	87
Hebei	81
San Mateo	76
Changsha	70
Falls Church	68
Jiaxing	66
Rome	63
Ferrara	62
Tianjin	58
Jinan	57
Mountain View	47
Verona	42
Ningbo	39
Philadelphia	39
Zhengzhou	39
Bremen	38
Redwood City	37
Taizhou	36
Warsaw	30
Norwalk	27
Addison	25
Napoli	24
Indiana	22
London	22
Kunming	20
Naples	19
Des Moines	18
Orange	18
Chicago	16
Hangzhou	16
Brussels	15
Dearborn	14
Dong Ket	14
Genova	14
Guangzhou	14
Bologna	12
Changchun	11
Florence	11
New York	11
Redmond	11
Bari	10
Shanghai	10
Palermo	9
Torino	9
Brescia	8
Yellow Springs	8
Auburn Hills	7
Catania	7
Haikou	7
Lanzhou	7
Los Angeles	7
Padova	7
Modena	6
Washington	6
Cagliari	5
Caserta	5
Como	5
Fuzhou	5
Livorno	5
Monmouth Junction	5
Pozzo Di Gotto	5
Siena	5
Genoa	4
Granada	4
Leawood	4
Omegna	4
Parma	4
Pisa	4
Ravenna	4
Trento	4
Bacoli	3
Bellinzago Novarese	3
Casalgrande	3
Domaso	3
Figline Valdarno	3
Helsinki	3
Latina	3
Liebenau	3
Marsala	3
Pescara	3
Reggio Nell'emilia	3
San Francisco	3
Totale	16361

Salva come PNG Salva come JPEG

Nome	#
IL METABOLISMO DEL MIOCARDIO ISCHEMICO IBERNATO E STORDITO: DIFFERENZA TRA NECROSI E APOPTOSI	1453
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	153
Effects of temperature on myocardial calcium homeostasis and mitochondrial function during ischemia and reperfusion.	148
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL	144
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study	134
Enhanced expression and activity of xanthine oxidoreductase in the failing heart.	131
Uric acid and coronary artery disease: An elusive link deserving further attention	128
Prolonged propionyl-L-carnitine pre-treatment of rabbit: biochemical, hemodynamic and electrophysiological effects on myocardium.	126
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management	126
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).	119
Time course of human atrial natriuretic factor release during cardiopulmonary bypass in mitral valve and coronary artery diseased patients.	110
Third Universal Definition of Myocardial Infarction	110
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy	109
A way forward to the elimination of conflict of interest for experts involved in regulatory medicine and guidelines	108
Postinfarction left ventricular free wall rupture: original management and surgical technique.	107
null	106
null	106
Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium?	105
Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)	105
Link between chronic obstructive pulmonary disease and coronary artery disease: Implication for clinical practice	104
Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression	104
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis	104
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals	104
Effects of iloprost (ZK 36374) on glutathione status during ischaemia and reperfusion of rabbit isolated hearts.	103
Specific properties and effect of perindopril in controlling the renin-angiotensin system.	103
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes	103
Abnormalities of left ventricular function in asymptomatic patients with systemic sclerosis using doppler measures of myocardial strain.	103
In vitro administration of ergothioneine failed to protect isolated ischaemic and reperfused rabbit heart	103
Right heart failure chronically stimulates heat shock protein 72 in heart and liver but not in other tissues.	103
Effects of endotoxic shock on neuronal NOS and calcium transients in rat cardiac myocytes	103
2015 ESC Guidelines for the diagnosis and management of pericardial diseases The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)	103
Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE	103
Occurrence of oxidative stress during reperfusion of the human heart.	102
Is stunning an important component of preconditioning?	102
Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling.	102
Relevance of apoptosis in influencing recovery of hibernating myocardium	102
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation	102
Selective and specific I f inhibition with ivabradine: New perspectives for the treatment of cardiovascular disease	101
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association.	101
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD	101
Plasma levels of atrial natriuretic factor (ANF) and urinary excretion of ANF, arginine vasopressin and catecholamines in children with congenital heart disease: effect of cardiac surgery.	100
Differences in the effect of angiotensin-converting enzyme inhibitors on the rate of endothelial cell apoptosis: in vitro and in vivo studies	100
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98))	100
Revascularization of hibernating myocardium: rate of metabolic and functional recovery and occurrence of oxidative stress.	99
Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability.	99
ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC).	99
Secondary Prevention of CAD with ACE Inhibitors: A Struggle Between Life and Death of the Endothelium	99
Changes in oxidative stress and cellular redox potential during myocardial storage for transplantation: experimental studies.	98
Noradrenaline, atrial natriuretic peptide, bombesin and neurotensin in myocardium and blood of rats in congestive cardiac failure.	98
Effect of superoxide generation on rat heart mitochondrial pyruvate utilization.	98
Chromogranin A in heart failure - A novel neurohumoral factor and a predictor for mortality	98
Pathophysiological role of heart rate: from ischaemia to left ventricular dysfunction	98
Third universal definition of myocardial infarction	98
Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction.	98
Incremental exercise using progressive versus constant pedaling rates: A study in cardlac patients	98
Oxygen free radicals and myocardial damage: protective role of thiol-containing agents.	97
Oxygen free radicals and reperfusion injury; the effect of ischaemia and reperfusion on the cellular ability to neutralise oxygen toxicity.	97
Oxygen Free Radicals in Shock	97
Evidence against malondialdehyde bound to cellular constituents in phospholipid peroxidation	97
Anti-ischemic effect of IVA in isolated rabbit hearts: Modulation of cardiac metabolism	97
Anti-ischaemic effect of ivabradine	96
Traditional and new composite endpoints in heart failure clinical trials: Facilitating comprehensive efficacy assessments and improving trial efficiency	96
The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: Study protocol for a randomized controlled trial	96
Role of A2A receptor in the modulation of myocardial reperfusion damage.	96
Effects of felodipine on the ischemic heart: insight into the mechanism of cytoprotection.	95
Left ventricular dysfunction due to stunning and hibernation in patients.	95
New insights on myocardial pyridine nucleotides and thiol redox state in ischemia and reperfusion damage.	95
Different outcomes of the reperfused myocardium: insights into the comments of stunning and hibernation.	95
Metabolic adaptation during a sequence of no-flow and low-flow ischemia. A possible trigger for hibernation.	95
Myocardial damage during ischaemia and reperfusion.	95
null	95
Mechanical vs. electrical dyssynchrony for CRTselection in patients with HF	95
Efficacy of Ivabradine in Combination with Beta-Blocker Versus Uptitration of Beta-Blocker in Patients with Stable Angina	95
Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition	95
Effect of L-carnitine derivatives on heart mitochondrial damage induced by lipid peroxidation.	95
Oxidative stress during myocardial ischaemia and heart failure.	94
Protective effect of a prostacyclin-mimetic on the ischaemic-reperfused rabbit myocardium.	94
Metabolic changes during post-ischaemic reperfusion.	94
The ACE-inhibitor Perindoprilat has high selectivity for bradykinin binding sites of human somatic ACE	94
null	94
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).	94
null	94
Cardioprotection by nisoldipine: role of timing of administration.	93
The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria.	93
One heart, two lungs together forever	93
Preventive cardiology: comparisons of European and Italian projects with the Cardiac Units from Emilia Romagna region. A workshop of IACPR/GICR - Emilia Romagna	93
The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine.	93
Continuous versus intermittent warm blood cardioplegia: functional and energetics changes.	93
Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease	93
Myocardial recovery during post-ischaemic reperfusion: effects of nifedipine, calcium and magnesium.	92
Skeletal muscle abnormalities in rats with experimentally induced heart hypertrophy and failure.	92
The occurrence of oxidative stress during reperfusion in experimental animals and men.	92
Protective effect of propionyl-L-carnitine against ischaemia and reperfusion-damage.	92
The ACE-inhibitor perindoprilat has high selectivity for bradykinin binding sites of human somatic ACE	92
Effect of ivabradine on structural and electrophysiological remodelling in a rat model of heart failure	92
Guidelines on myocardial revascularization	92
Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review	92
Ace inhibition with perindopril and markers of atherosclerosis and thrombosis: Results of the pertinent study	92
Left ventricular dysfunction due to the new ischemic outcomes: stunning and hibernation.	92
Lipid peroxidation in normal pregnancy and preeclampsia	91
Totale	11498

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	39183
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	2459
Totale	41642

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2017/2018	264	0	0	0	0	0	0	0	0	35	168	36	25
2018/2019	3770	34	17	46	175	40	34	339	28	246	607	820	1384
2019/2020	5399	881	186	185	803	419	606	454	585	418	577	165	120
2020/2021	3361	295	343	198	452	178	362	78	437	76	438	353	151
2021/2022	2999	85	374	306	82	107	137	167	151	100	187	262	1041
2022/2023	2011	277	29	78	259	391	382	61	251	283	0	0	0
Totale													21745